Summary
The mechanism by which dietary phosphate deprivation elevates plasma 1,25-(OH)2-D levels is not known. To evaluate the role of the pituitary in regulating plasma 1,25-(OH)2-D concentrations, the responses of plasma 1,25-(OH)2-D to dietary phosphate deprivation and, separately, to dietary calcium deprivation were evaluated in intact and hypophysectomized male rats. Among intact and hypophysectomized rats eating normal diets, plasma 1,25-(OH)2-D levels averaged 228±76 and 148±62 pmol/1, respectively (P<0.01). During dietary phosphate deprivation, plasma 1,25-(OH)2-D levels rose to 1160±260 in intact rats and fell to 90±26 pmol/l in hypophysectomized rats (P<0.001). By contrast, during dietary calcium deprivation, plasma 1,25-(OH)2-D levels rose in both intact and hypophysectomized animals to 856±107 and 742±279 pmol/l, respectively (NS). In response to dietary phosphate deprivation, serum calcium concentrations rose as 1,25-(OH)2-D concentrations rose in intact rats but remained at control levels in hypophysectomized rats. These results support the hypothesis that a pituitary hormone acting either directly or indirectly on the kidney mediates the increase in plasma 1,25-(OH)2-D during dietary phosphate deprivation. The hypercalcemia that occurs in rats during dietary phosphate deprivation appears to depend on the elevation of plasma 1,25-(OH)2-D.
Similar content being viewed by others
References
Hughes, M. R., Haussler, M. R., Wergedal, J., Baylink, D. J.: Regulation of serum 1α,25-dihydroxyvitamin D3 by calcium and phosphate in the rat, Science190:578, 1975
Rader, J. I., Baylink, D. J., Hughes, M. R., Safilian, E. F., Haussler, M. R.: Calcium and phosphorus deficiency in rats: effects on PTH and 1,25-dihydroxyvitamin D3, Am. J. Physiol.236:E118–122, 1979
Tanaka, Y., DeLuca, H. F.: The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus, Arch. Biochem. Biophys.154:566, 1973
Gray, R. W.: Effects of age and sex on the regulation of plasma 1,25-(OH)2-D by phosphorus in the rat, Calcif. Tissue Int.33, 477–484, 1981
Spanos, E., Burnett, D., MacIntyre, I., Pike, J. W., Safilian, E. J., Haussler, M. R.: Effect of growth hormone on vitamin D metabolism, Nature273:246–247, 1978
Trechsel, U., Bonjour, J.-P., Fleisch, H.: Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells, J. Clin. Invest.64:206–217, 1979
Caldas, A. E., Gray, R. W., Lemann, J. Jr.: The simultaneous measurement of vitamin D metabolites in plasma: studies in healthy adults and in patients with calcium nephrolithiasis, J. Lab. Clin. Med.91:840–849, 1978
Gray, R. W., Wilz, D. R., Caldas, A. E., Lemann, J. Jr.: The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects, in calcium-stone formers and in patients with primary hyperparathyroidism, J. Clin. Endocrinol. Metab.45:299–306, 1977
Snedecor, G. W., Cochran, W. G.: Statistical Methods, ed. 6. Iowa State University Press, Ames, Iowa, 1967
Garabedian, M., Holick, M. F., DeLuca, H. F., Boyle, I. T.: Control of 25-hydroxycholecalciferol metabolism by the parathyroid glands, Proc. Natl. Acad. Sci. U.S.A.69:1673–1976, 1972
Bilezikian, J. P., Canfield, R. E., Jacobs, T. P., Polay, J. S., D'Adama, A. P., Eisman, J. A., DeLuca, H. F.: Response of 1α,25-dihydroxyvitamin D3 to hypocalcemia in human subjects, N. Engl. J. Med.299:437, 1978
Adams, N. D., Gray, R. W., Lemann, J. Jr.: The effects of oral CaCO3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults, J. Clin. Endocrinol. Metab.48:1008–1016, 1979
Gertner, J. M., Horst, R. L., Broadus, A. E., Rasmussen, H., Gene, M.: Parathyroid function and vitamin D metabolism during human growth hormone replacement, J. Clin. Endocrinol. Metab.49:185–188, 1979
Eskildsen, P. C., Lund, B. J., Sorensen, O. H., Lund, B. I., Bishop, J. E., Norman, A. W.: Acromegaly and vitamin D metabolism: effect of bromocriptine treatment, J. Clin. Endocrinol. Metab.49:484–486, 1979
Brown, D. J., Spanos, E., Raptis, P., MacIntyre, I.: Effect of pregnancy, acromegaly, primary hyperparathyroidism and prolactinoma on 1,25-dihydroxyvitamin D in man. In A. W. Norman, K. Schaefer, D. v. Herrath, H.-G. Grigoleit, J. W. Coburn, H. F. DeLuca, E. B. Mawer, T. Suda (eds.): Vitamin D Basic Research and Its Clinical Application, pp. 625–635. Walter de Gruyter, New York, 1979
Kumar, R., Merimee, T. J., Silva, P., Epstein, F. H.: The effect of chronic excess or deficiency of growth hormone on plasma 1,25-dihydroxyvitamin D levels in man. In A. W. Norman, K. Schaefer, D. v. Herrath, H.-G. Grigoleit, J. W. Coburn, H. F. DeLuca, E. B. Mawer, T. Suda (eds.): Vitamin D Basic Research and Its Clinical Application, pp. 1005–1009. Walter de Gruyter, New York, 1979
Lee, D. B. N., Brautbar, N., Walling, M. W., Silis, V., Carlson, H. E., Grindeland, R. E., Coburn, J. W., Kleeman, C. R.: The role of growth hormone in experimental phosphorus depletion, Calcif. Tissue Int.32:105, 1980
Spanos, E.K., Colston, K. W., Evans, I. M. S., Galante, L. S., Macauley, S. I., MacIntyre, I.: Effect of prolactin on vitamin D metabolism, Mol. Cell Endocrinol.5:163, 1978
Spanos, E., Pike, J. W., Haussler, M. R., Colston, K. W., Evans, I. M. A., Goldner, A. M., McCain, T. A., MacIntyre, I.: Circulating 1α,25-dihydroxyvitamin D in the chicken: enhancement by injection of prolactin and during egg laying, Life Sci.19:1751, 1976
Adams, N. D., Garthwaite, T. L., Gray, R. W., Hagen, T. C., Lemann, J. Jr.: The interrelationships among prolactin, 1,25-dihydroxyvitamin D, and parathyroid hormone in humans, J. Clin. Endocrinol. Metab.49:628–630, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gray, R.W. Control of plasma 1,25-(OH)2-vitamin D concentrations by calcium and phosphorus in the rat: Effects of hypophysectomy. Calcif Tissue Int 33, 485–488 (1981). https://doi.org/10.1007/BF02409478
Issue Date:
DOI: https://doi.org/10.1007/BF02409478